CN1976694A - 用于治疗变应性疾病的局部用制剂 - Google Patents

用于治疗变应性疾病的局部用制剂 Download PDF

Info

Publication number
CN1976694A
CN1976694A CNA2005800213736A CN200580021373A CN1976694A CN 1976694 A CN1976694 A CN 1976694A CN A2005800213736 A CNA2005800213736 A CN A2005800213736A CN 200580021373 A CN200580021373 A CN 200580021373A CN 1976694 A CN1976694 A CN 1976694A
Authority
CN
China
Prior art keywords
alkyl
nhc
compound
oxepin
allergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2005800213736A
Other languages
English (en)
Chinese (zh)
Inventor
M·R·赫勒贝格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of CN1976694A publication Critical patent/CN1976694A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CNA2005800213736A 2004-06-28 2005-06-27 用于治疗变应性疾病的局部用制剂 Pending CN1976694A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58338004P 2004-06-28 2004-06-28
US60/583,380 2004-06-28

Publications (1)

Publication Number Publication Date
CN1976694A true CN1976694A (zh) 2007-06-06

Family

ID=35502431

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2005800213736A Pending CN1976694A (zh) 2004-06-28 2005-06-27 用于治疗变应性疾病的局部用制剂

Country Status (11)

Country Link
US (1) US20050288283A1 (https=)
EP (1) EP1761259A2 (https=)
JP (1) JP2008504300A (https=)
KR (1) KR20070024618A (https=)
CN (1) CN1976694A (https=)
AU (1) AU2005259911A1 (https=)
BR (1) BRPI0512732A (https=)
CA (1) CA2569519A1 (https=)
MX (1) MXPA06014648A (https=)
WO (1) WO2006004757A2 (https=)
ZA (1) ZA200610350B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106117176A (zh) * 2016-06-24 2016-11-16 四川大学 二氢双苯并恶庚衍生物及其组合物与应用

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070225356A1 (en) * 2004-04-21 2007-09-27 Kyowa Hakko Kogo Co., Ltd Preventive and/or Therapeutic Agent for Chronic Sinusitis
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8222419B2 (en) * 2006-09-29 2012-07-17 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative
JP5564060B2 (ja) * 2009-02-05 2014-07-30 ザック システム エス．ピー．エー． オロパタジン及び／又はその薬学的に許容され得る塩の製造方法
WO2014026611A1 (en) * 2012-08-14 2014-02-20 Huawei Technologies Co., Ltd. Rollback method and apparatus of transaction, relational database management system

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU2001255675B2 (en) * 2000-05-19 2005-04-14 Alcon, Inc. Disulfide derivatives useful for treating allergic diseases
DK1289945T3 (da) * 2000-05-19 2004-11-01 Alcon Inc Anilindisulfidderivater til behandling af allergiske sygdomme
DK1284722T3 (da) * 2000-05-19 2005-09-19 Alcon Inc Sammensætninger indeholdende et benzamiddisulfidderivat til behandling af allergiske sygdomme
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106117176A (zh) * 2016-06-24 2016-11-16 四川大学 二氢双苯并恶庚衍生物及其组合物与应用
CN106117176B (zh) * 2016-06-24 2018-12-11 四川大学 二氢双苯并恶庚衍生物及其组合物与应用

Also Published As

Publication number Publication date
JP2008504300A (ja) 2008-02-14
WO2006004757A3 (en) 2006-03-09
WO2006004757A2 (en) 2006-01-12
MXPA06014648A (es) 2007-02-12
KR20070024618A (ko) 2007-03-02
EP1761259A2 (en) 2007-03-14
US20050288283A1 (en) 2005-12-29
BRPI0512732A (pt) 2008-04-08
ZA200610350B (en) 2008-12-31
AU2005259911A1 (en) 2006-01-12
CA2569519A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
CN1250549C (zh) 吲哚衍生物及其作为5－ht2b和5－ht2c受体配体的应用
CN1041087C (zh) 芳基乙酰胺及其制备方法和应用
CN1118460C (zh) 作为5HTzc-受体拮抗剂的嘧啶衍生物
CN1100774C (zh) 具有高效钙拮抗物和抗氧化剂活性的化合物及其用作细胞保护剂
CN1215060C (zh) 稠合的吡唑基化合物、包含该化合物的组合物及该化合物的应用
CN1083431C (zh) 新的杂环化合物
CN1812963A (zh) 用于治疗阿尔茨海默病的N－烷基苯基甲酰胺β分泌酶抑制剂
CN1111245A (zh) 雪花胺衍生物、其制备方法及其作为药物的用途
CN1468224A (zh) 用作α-2拮抗剂的喹啉衍生物
CN1039910C (zh) 雪花胺衍生物、其制备方法及其作为药物的用途
CN1191248C (zh) 作为多巴胺d 受体亚型配体的1－(2－萘基)和1－(2－氮杂萘基)－4－(1－苯基甲基)哌嗪
CN1149046A (zh) 新的取代2，2-二甲基-ω-苯氧链烷酸及酯，其制备方法及含有它们的药物组合物
CN1512879A (zh) 新的芳氨基丙烷类似物及其用于治疗青光眼的用途
CN1031084A (zh) 具有抗过敏作用的新的苯并噻吩和具有治疗急性呼吸困难综合症作用的新的和其他选用的苯并噻吩
CN1976694A (zh) 用于治疗变应性疾病的局部用制剂
CN1070911A (zh) 治疗化合物
CN1097006A (zh) O-芳基吗啡喃的醚类化合物
CN1059433C (zh) 新的芳基烷基(硫代)甲酰胺,制备此类酰胺的方法和含此类酰胺的药物组合物
CN1956962A (zh) 四氢异喹啉磺酰胺衍生物，其制备方法及其在治疗中的应用
CN1017426B (zh) 烷基褪黑激素的制备方法
CN1055472C (zh) 噁唑并喹啉酮衍生物,它们的制备及其在治疗上的应用
CN1065269A (zh) 哒嗪酮乙酸衍生物
CN1090629C (zh) 新的杂环化合物
CN1191528A (zh) 具有褪黑激素受体结合亲合力的苯并环烯化合物,其生产方法和用途
CN1087337A (zh) 取代的喹啉-2-基甲氧基苯乙酸衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication